|
|
||||||||||||||||||
|
|
NIST
GCR 04-863
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
The “Cluster Performance Metrics” circle represents the calculation of performance measures by comparing combined cash flow benefits to ATP’s investment in the cluster of five projects. The metrics generated for the cluster, net present value (NPV), benefit-to-cost ratio, and internal rate of return (IRR), measure public returns against public investments.
Similarly, the “Program Performance Metrics” circle represents the calculation of performance measures by comparing combined cash flow benefits to ATP’s investment in a program of 22 projects. The metrics generated for the program, NPV, benefit-to-cost ratio, and IRR measure public returns against public investments in the focused program. Given that program metrics are derived by comparing cash flow benefits from two projects to a much larger program investment, performance metrics for the focused program, while still at significant levels, have lower values than metrics for the cluster of five projects.
ECONOMIC ANALYSIS
The flow of benefits in Figure 11, from the two cases study projects and from the remaining three projects in the cluster, are directly attributable to the ATP.
Industry partners for the five cluster projects have indicated that, for various reasons specific to each high-risk technology project, development programs would not have been undertaken without ATP funding. In addition, industry partners for the two projects with currently quantifiable cash flow benefits stressed the value of ATPfacilitated industry joint ventures as essential ingredients for successful technical development and commercialization.
Base Case Analysis
The base case analysis represents a conservative set of assumptions regarding expected benefits from ATP-funded technology development. On the benefit side, combined cash flows from the commercial utilization of two technologies for which quantifiable benefits are currently available (VGCF and CPR), covering the period of 2004 to 2026, are used to characterize both cluster and program performance, as summarized in Table 9. Combined cash flow estimates reflect the following assumptions:
On the cost side, ATP invested $9.4 million and industry partners invested $7.8 million in the cluster of five projects. To fund the 22-project focused program, ATP invested $43.5 million and industry partners invested $39.0 million. Normalized to 2003 dollars, the ATP investment for the cluster was $10.90 and $50.45 million for the program.
In Table 9 column 2, normalized ATP cluster project investments are negative entries over the 1995 to 1998 investment period; combined VGCF and CPR cash flow benefits are positive entries during the 2004 to 2026 “benefit generation years.”
Table 9: Combined Cash Flows of ATP Investments and Expected Benefits from VGCF and CPR Deployment ($ Millions, in 2003 Dollars): Base Case
| Year | ATP
cluster investments in five projects and combined cash flows from VGCF and CPR projects (see note below) |
ATP
program investments in 22 projects and combined cash flows from VGCF and CPR projects (see note below |
| Investment years | ||
| 1995 | -1.24 | -6.92 |
| 1996 | -2.34 | -17.47 |
| 1997 | -4.81 | -23.55 |
| 1998 | -2.51 | -2.51 |
| Benefit generation years | ||
| 2004 | 2.17 | 2.17 |
| 2005 | 6.50 | 6.50 |
| 2006 | 20.18 | 20.18 |
| 2007 | 116.06 | 116.06 |
| 2008 | 57.05 | 57.05 |
| 2009 | 172.69 | 172.69 |
| 2010 | 125.01 | 125.01 |
| 2011 | 222.27 | 222.27 |
| 2012 | 158.91 | 158.91 |
| 2013 | 256.93 | 256.93 |
| 2014 | 190.94 | 190.94 |
| 2015 | 286.76 | 286.76 |
| 2016 | 220.88 | 220.88 |
| 2017 | 314.29 | 314.29 |
| 2018 | 251.50 | 251.50 |
| 2019 | 352.20 | 352.20 |
| 2020 | 291.42 | 292.42 |
| 2021 | 397.18 | 397.18 |
| 2022 | 68.02 | 68.02 |
| 2023 | 143.98 | 143.98 |
| 2024 | 60.42 | 60.42 |
| 2025 | 135.27 | 135.27 |
| 2026 | 47.62 | 47.62 |
Note: Combined cash flows are computed from “Total cash flow” columns in Tables 2 and 7.
In Table 9, column 3, normalized ATP investments in the 22 projects of the focused program are negative entries over the 1995 to 1998 investment period and combined VGCF and CPR cash flow benefits are positive entries during the 2004 to 2026 “benefit generation years.”
Base Case Performance Metrics
Cash flow time series over the 1995 to 2026 period, comprised of ATP investments and expected benefits (from Table 9, column 2), are used to compute performance metrics for the cluster of projects. These cluster performance metrics (NPV of $892 million, benefit-to-cost ratio of $83, and IRR of 44 percent) are indicated in Table 10, column 2.
Cash flow time series over the 1995 to 2026 period, comprised of ATP investments and expected benefits (from Table 9, column 3), are used to compute performance metrics for the focused program . These program performance metrics (NPV of $858 million, benefit-to-cost ratio of $18, and IRR of 29 percent) are indicated in Table 10, column 3.
Table 10 cluster and program performance metrics indicate excellent returns to taxpayers from ATP’s investments in composites manufacturing technologies, as highlighted below:
• For every dollar of ATP’s $9.4 million investment in the cluster of five projects, U.S. industry, U.S. consumers, and the nation will enjoy $83 of quantifiable benefits over the projected economic life of the VGCF and CPR technologies. • For every dollar of ATP’s $43.5 million investment in the program of 22 projects, U.S. industry, U.S. consumers, and the nation will enjoy $18 of quantifiable benefits over the projected economic life of the VGCF and CPR technologies. Even though these results should be interpreted as preliminary and actual results could be stronger if more projects were analyzed in depth, the entire focused program investment yielded far greater benefits than its cost to taxpayers.
Table 10: Base Case Performance Metrics from Combined VGCF and CPR Cash Flows against ATP Cluster and ATP Program Investments (in 2003 Dollars)
| Performance metrics cluster of five projects | Performance metrics program of 22 projects | |
| Net present value Benefit-to-cost ratio Internal rate of return |
$892
million 83:1 44% |
$858
million 18:1 29% |
Note: A 1995 base year and an OMB-mandated 7 percent discount rate were used for analysis. Performance metrics were computed from time series representing ATP investments over the 1995 to 1998 period and prospective cash flow benefits from 2004 to 2026.
These measures reflect the estimated benefits to industry users and the general public relative to the ATP investment. Estimated benefits to direct recipients of ATP funding are excluded.
Most Significant Sources of Benefits
The results of a component analysis of the base case NPV for the cluster of five projects are presented in Figure 12. NPV contributions from VGCF deployment and CPR deployment are of similar magnitude at 49 and 52 percent, respectively. NPV contributions from CPR deployment are evenly split between capital cost savings and royalties to the U.S. Minerals Management Service, whereas contributions from VGCF for electrostatic painting dwarf the small (9 percent) contribution from VGCF use in EMI shielding.
Figure 12: Net Present Value Component Analysis: Base Case
![]() |
Step-Out Scenario Analysis
The step-out scenario is based on more optimistic assumptions about expected benefits from ATP-funded technologies. Benefit estimates are somewhat higher and ATP investments are the same as for base case analysis.
Cash flow time series over the 1995 to 2026 period, comprised of ATP investments and expected benefits, are used to compute performance metrics for the cluster of projects. These cluster performance metrics (NPV of $994 million, benefit-to-cost ratio of $92, and IRR of 46 percent) are indicated in Table 11, column 2.
Cash flow time series over the 1995 to 2026 period, comprised of ATP investments and expected benefits, are used to compute performance metrics for the focused program . These program performance metrics (NPV of $960 million, benefit-to-cost ratio of $20, and IRR of 30 percent) are indicated in Table 11, column 3.
Table 11: Step-Out Scenario Performance Metrics from Combined VGCF and CPR
| Performance metrics cluster of five projects | Performance metrics program of 22 projects | |
| Net present value Benefit-to-cost ratio Internal rate of return |
$994
million 92:1 46% |
$960
million 20:1 30% |
Note: A 1995 base year and an OMB-mandated 7 percent discount rate were used for analysis. Performance metrics were computed from time series representing ATP investments over the 1995 to 1998 period and prospective cash flow benefits from 2004 to 2026.
FUTURE EXTENSION OF CASH FLOW BENEFITS
While some public benefits expected to be realized from the cluster of five projects could not be meaningfully quantified at this time, these potential benefits could become important for U.S. industry, consumers, and society at large in the future.
Two examples are given below.
If the above technologies should progress toward successful commercialization, over time, the estimation of additional cash flow benefits could be warranted. This, turn, would lead to an upward adjustment of performance metrics presented in the current study.
Given the potential for additional cash flow benefits from future analysis, it is clear that the levels of performance reported in this study (based on cash flow benefit streams from only two ATP-funded projects) provide conservative, lower-bound estimates of cluster performance and program performance.
Return to Table of Contents or go to next section.
Date created: July 14,
2004
Last updated:
August 3, 2005
ATP website comments: webmaster-atp@nist.gov / Technical ATP inquiries: InfoCoord.ATP@nist.gov. NIST is an agency of the U.S. Commerce Department |